Neuromuscular blocking drugs.
D001919:Bradycardia / Q000139:chemically induced; D002802:Cholinesterases / Q000378:metabolism; D005703:Gallamine Triethiodide; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007223:Infant; D007231:Infant, Newborn; D007429:Intraocular Pressure / Q000187:drug effects; D008991:Monitoring, Physiologic; D009135:Muscular Diseases / Q000139:chemically induced; D009222:Myotonia / Q000139:chemically induced; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D010197:Pancuronium; D011183:Postoperative Complications; D013390:Succinylcholine / Q000009:adverse effects; D013997:Time Factors; D014403:Tubocurarine / Q000031:analogs & derivatives
D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D002802:Cholinesterases; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; C032943:metocurine; D014403:Tubocurarine